RYNVX vs. PHPIX
Compare and contrast key facts about Rydex Nova Fund (RYNVX) and ProFunds Pharmaceuticals UltraSector Fund (PHPIX).
RYNVX is managed by Rydex Funds. It was launched on Jul 11, 1993. PHPIX is managed by ProFunds. It was launched on Jun 27, 2000.
Performance
RYNVX vs. PHPIX - Performance Comparison
Loading graphics...
RYNVX vs. PHPIX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RYNVX Rydex Nova Fund | -11.41% | 21.42% | 33.14% | 35.31% | -29.96% | 42.56% | 19.64% | 45.58% | -10.24% | 31.17% |
PHPIX ProFunds Pharmaceuticals UltraSector Fund | -13.41% | 41.41% | 1.36% | -11.28% | -10.73% | 28.10% | 15.48% | 19.98% | -14.91% | 10.19% |
Returns By Period
In the year-to-date period, RYNVX achieves a -11.41% return, which is significantly higher than PHPIX's -13.41% return. Over the past 10 years, RYNVX has outperformed PHPIX with an annualized return of 16.20%, while PHPIX has yielded a comparatively lower 5.08% annualized return.
RYNVX
- 1D
- -0.59%
- 1M
- -11.64%
- YTD
- -11.41%
- 6M
- -8.94%
- 1Y
- 16.27%
- 3Y*
- 20.70%
- 5Y*
- 12.22%
- 10Y*
- 16.20%
PHPIX
- 1D
- -1.54%
- 1M
- -15.65%
- YTD
- -13.41%
- 6M
- 8.28%
- 1Y
- 20.02%
- 3Y*
- 7.16%
- 5Y*
- 5.13%
- 10Y*
- 5.08%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
RYNVX vs. PHPIX - Expense Ratio Comparison
RYNVX has a 1.23% expense ratio, which is lower than PHPIX's 1.78% expense ratio.
Return for Risk
RYNVX vs. PHPIX — Risk / Return Rank
RYNVX
PHPIX
RYNVX vs. PHPIX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Rydex Nova Fund (RYNVX) and ProFunds Pharmaceuticals UltraSector Fund (PHPIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| RYNVX | PHPIX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.64 | 0.75 | -0.11 |
Sortino ratioReturn per unit of downside risk | 1.07 | 1.20 | -0.13 |
Omega ratioGain probability vs. loss probability | 1.16 | 1.15 | +0.01 |
Calmar ratioReturn relative to maximum drawdown | 0.77 | 1.02 | -0.26 |
Martin ratioReturn relative to average drawdown | 3.48 | 2.91 | +0.58 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| RYNVX | PHPIX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.64 | 0.75 | -0.11 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.47 | 0.19 | +0.29 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.59 | 0.19 | +0.41 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.38 | 0.11 | +0.27 |
Correlation
The correlation between RYNVX and PHPIX is 0.65, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
RYNVX vs. PHPIX - Dividend Comparison
RYNVX's dividend yield for the trailing twelve months is around 0.85%, less than PHPIX's 1.03% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
RYNVX Rydex Nova Fund | 0.85% | 0.76% | 0.66% | 0.59% | 22.11% | 9.07% | 0.53% | 0.00% | 0.00% | 1.97% | 1.22% | 0.13% |
PHPIX ProFunds Pharmaceuticals UltraSector Fund | 1.03% | 0.89% | 1.06% | 0.48% | 0.00% | 11.83% | 0.38% | 0.00% | 4.17% | 0.00% | 0.00% | 0.08% |
Drawdowns
RYNVX vs. PHPIX - Drawdown Comparison
The maximum RYNVX drawdown since its inception was -76.54%, roughly equal to the maximum PHPIX drawdown of -77.37%. Use the drawdown chart below to compare losses from any high point for RYNVX and PHPIX.
Loading graphics...
Drawdown Indicators
| RYNVX | PHPIX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.54% | -77.37% | +0.83% |
Max Drawdown (1Y)Largest decline over 1 year | -17.91% | -19.35% | +1.44% |
Max Drawdown (5Y)Largest decline over 5 years | -40.92% | -39.21% | -1.71% |
Max Drawdown (10Y)Largest decline over 10 years | -48.58% | -45.46% | -3.12% |
Current DrawdownCurrent decline from peak | -13.84% | -17.65% | +3.81% |
Average DrawdownAverage peak-to-trough decline | -19.72% | -31.88% | +12.16% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.94% | 8.40% | -4.46% |
Volatility
RYNVX vs. PHPIX - Volatility Comparison
The current volatility for Rydex Nova Fund (RYNVX) is 6.38%, while ProFunds Pharmaceuticals UltraSector Fund (PHPIX) has a volatility of 11.33%. This indicates that RYNVX experiences smaller price fluctuations and is considered to be less risky than PHPIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| RYNVX | PHPIX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.38% | 11.33% | -4.95% |
Volatility (6M)Calculated over the trailing 6-month period | 13.61% | 22.92% | -9.31% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.19% | 35.40% | -8.21% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.89% | 27.47% | -1.58% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.33% | 27.53% | -0.20% |